Lemonade, Inc.
Lemonade, Inc. (LMND) Financial Performance & Income Statement Overview
Explore the financials of Lemonade, Inc. (LMND), including yearly and quarterly data on income, cash flow, and balance sheets.
Lemonade, Inc. (LMND) Income Statement & Financial Overview
View the income breakdown for Lemonade, Inc. LMND across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $151.20M | $148.80M | $136.60M | $122.00M |
| Cost of Revenue | $111.50M | $53.10M | $97.70M | $89.30M |
| Gross Profit | $39.70M | $95.70M | $38.90M | $32.70M |
| Gross Profit Ratio | $0.26 | $0.64 | $0.28 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $79.10M | $81.20M | $82.80M | $66.60M |
| Operating Expenses | $101.10M | $133.50M | $104.70M | $87.80M |
| Total Costs & Expenses | $212.60M | $186.60M | $202.40M | $177.10M |
| Interest Income | $2.20M | $2.50M | $2.00M | $2.20M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4.50M | $4.70M | $5.10M | $5.20M |
| EBITDA | -$56.90M | -$33.10M | -$60.70M | -$49.90M |
| EBITDA Ratio | -$0.38 | -$0.22 | -$0.44 | -$0.41 |
| Operating Income | -$61.40M | -$37.80M | -$65.80M | -$55.10M |
| Operating Income Ratio | -$0.41 | -$0.25 | -$0.48 | -$0.45 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | -$61.40M | -$37.80M | -$65.80M | -$55.10M |
| Income Before Tax Ratio | -$0.41 | -$0.25 | -$0.48 | -$0.45 |
| Income Tax Expense | $1.00M | -$7.80M | $1.90M | $2.10M |
| Net Income | -$62.40M | -$30.00M | -$67.70M | -$57.20M |
| Net Income Ratio | -$0.41 | -$0.20 | -$0.50 | -$0.47 |
| EPS | -$0.86 | -$0.42 | -$0.95 | -$0.81 |
| Diluted EPS | -$0.86 | -$0.42 | -$0.95 | -$0.81 |
| Weighted Avg Shares Outstanding | $72.92M | $71.02M | $71.14M | $70.72M |
| Weighted Avg Shares Outstanding (Diluted) | $72.92M | $71.02M | $71.14M | $70.72M |
Over the past four quarters, Lemonade, Inc. demonstrated steady revenue growth, increasing from $122.00M in Q2 2024 to $151.20M in Q1 2025. Operating income reached -$61.40M in Q1 2025, maintaining a consistent -41% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$56.90M, reflecting operational efficiency. Net income dropped to -$62.40M, with EPS at -$0.86. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan